{
  "actions": [
    {
      "acted_at": "2022-08-02",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2022-08-02",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr8641-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "B001298",
      "district": "2",
      "name": "Bacon, Don",
      "original_cosponsor": true,
      "sponsored_at": "2022-08-02",
      "state": "NE",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000631",
      "district": "4",
      "name": "Dean, Madeleine",
      "original_cosponsor": true,
      "sponsored_at": "2022-08-02",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001180",
      "district": "5",
      "name": "Schrader, Kurt",
      "original_cosponsor": false,
      "sponsored_at": "2022-10-21",
      "state": "OR",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-08-02",
  "number": "8641",
  "official_title": "To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Orphan Drug COVID\u00e2\u20ac\u201c19 Mitigation Act of 2022",
  "sponsor": {
    "bioguide_id": "G000583",
    "district": "5",
    "name": "Gottheimer, Josh",
    "state": "NJ",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-08-02",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2022-08-02",
    "date": "2022-12-21T15:59:41Z",
    "text": "Orphan Drug COVID-19 Mitigation Act of 2022\n\nThis bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Orphan Drug COVID\u00e2\u20ac\u201c19 Mitigation Act of 2022",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Orphan Drug COVID\u00e2\u20ac\u201c19 Mitigation Act of 2022",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2022-12-29T19:03:42Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr8641.xml"
}